Ichnos and Glenmark take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance – ‘Ichnos Glenmark Innovation’ – Table

DATE: 30 Jan 2024 CATEGORY: PRESS RELEASE Ichnos and Glenmark take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - ‘Ichnos Glenmark Innovation’ FOR IMMEDIATE RELEASENEW…

Continue ReadingIchnos and Glenmark take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance – ‘Ichnos Glenmark Innovation’ – Table

Ichnos Glenmark Innovation reports the publication in Nature Communications of the preclinical development of ISB 1442 bispecific antibody for Treatment of Relapsed/Refractory Multiple Myeloma

DATE: 08 March 2024 CATEGORY: PRESS RELEASE Ichnos Glenmark Innovation reports the publication in Nature Communications of the preclinical development of ISB 1442 bispecific antibody for Treatment of Relapsed/Refractory Multiple…

Continue ReadingIchnos Glenmark Innovation reports the publication in Nature Communications of the preclinical development of ISB 1442 bispecific antibody for Treatment of Relapsed/Refractory Multiple Myeloma